[go: up one dir, main page]

CN107468752A - A kind of compound Danshen Root sticks micropill and its preparation technology - Google Patents

A kind of compound Danshen Root sticks micropill and its preparation technology Download PDF

Info

Publication number
CN107468752A
CN107468752A CN201710609695.7A CN201710609695A CN107468752A CN 107468752 A CN107468752 A CN 107468752A CN 201710609695 A CN201710609695 A CN 201710609695A CN 107468752 A CN107468752 A CN 107468752A
Authority
CN
China
Prior art keywords
parts
weight
borneol
micropill
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710609695.7A
Other languages
Chinese (zh)
Inventor
陆洋
杜守颖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing University of Chinese Medicine
Original Assignee
Beijing University of Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing University of Chinese Medicine filed Critical Beijing University of Chinese Medicine
Priority to CN201710609695.7A priority Critical patent/CN107468752A/en
Publication of CN107468752A publication Critical patent/CN107468752A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537Salvia (sage)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

本发明公开一种复方丹参黏附微丸及其制备方法,其主要特征在于取丹参,三七,冰片,丹参与三七分别采用70%乙醇提取,得到提取物,冰片采用倍他环糊精包合,取其包合物,利用挤出滚圆机制备微丸,本发明制备的复方丹参黏附微丸,可以使药物黏附于人体胃肠道黏膜,延长药物在胃肠道的停留时间,可显著提高复方丹参方的生物利用度,同时,冰片采用倍他环糊精包合,可提高冰片在制剂中的稳定性。

The invention discloses a compound Danshen adhered pellet and a preparation method thereof, which is mainly characterized in that Danshen, Panax notoginseng, borneol and Danshen notoginseng are respectively extracted with 70% ethanol to obtain the extract, and the borneol is wrapped with beta-cyclodextrin Take its clathrate, and use the extrusion spheronizer to prepare pellets. The compound salvia miltiorrhiza adhered pellets prepared by the present invention can make the drug adhere to the gastrointestinal mucosa of the human body, prolong the residence time of the drug in the gastrointestinal tract, and can significantly Improve the bioavailability of the compound Danshen formula, and at the same time, the inclusion of borneol with beta-cyclodextrin can improve the stability of borneol in the preparation.

Description

一种复方丹参黏附微丸及其制备工艺A kind of compound salvia miltiorrhiza adhered pellets and its preparation process

技术领域technical field

本发明涉及中药领域,具体是一种复方丹参黏附微丸及其制备工艺。The invention relates to the field of traditional Chinese medicines, in particular to compound salvia miltiorrhiza sticky pellets and a preparation process thereof.

背景技术Background technique

复方丹参制剂是名优中成药大品种之一,临床广泛用于治疗冠心病,心绞痛等心血管疾病,疗效确切。复方丹参方由三味中药组成,丹参,三七以及冰片。丹参中以丹参酮ⅡA为代表的脂溶性成分二萜醌类化合物溶出差,且以丹酚酸B和三七中皂苷类成分为代表的水溶性成分在胃液中的稳定性较差,冰片具有开窍醒神,清热散毒的功效,但冰片具有挥发性,长期放置可能导致制剂中药效成分含量降低。Compound salvia miltiorrhiza preparation is one of the large varieties of well-known Chinese patent medicines. It is widely used clinically to treat coronary heart disease, angina pectoris and other cardiovascular diseases with definite curative effect. Compound Salvia Recipe consists of three traditional Chinese medicines, Danshen, Panax notoginseng and Borneol. The fat-soluble components of Danshen, represented by tanshinone ⅡA, diterpene quinones are poorly dissolved, and the water-soluble components represented by salvianolic acid B and saponins in Panax notoginseng have poor stability in gastric juice. Refreshing, heat-clearing and toxin-dispelling effects, but borneol is volatile, and long-term storage may lead to a decrease in the content of medicinal ingredients in the preparation.

生物黏附技术可以解决药物在胃肠道内停留时间不足的问题,其通过增加药物与胃肠道黏膜之间的作用力,延长药物在胃肠道内的滞留时间,促进药物与黏膜的紧密接触,从而提高药物的生物利用度。采用倍他环糊精包合技术,可以有效防止生产及储存过程中冰片的挥发。Bioadhesion technology can solve the problem of insufficient residence time of drugs in the gastrointestinal tract. It increases the force between the drug and the gastrointestinal mucosa, prolongs the residence time of the drug in the gastrointestinal tract, and promotes the close contact between the drug and the mucosa. Improve the bioavailability of drugs. The inclusion technology of beta-cyclodextrin can effectively prevent the volatilization of borneol during production and storage.

发明内容Contents of the invention

本发明目的在于提供一种复方丹参黏附微丸,本发明目的是通过如下技术方案实现的:The object of the present invention is to provide a kind of compound Danshen adherent pellet, and the object of the present invention is realized through the following technical scheme:

一种复方丹参黏附微丸,称取丹参提取物6-10重量份,三七提取物1-3重量份,冰片包合物1-4重量份,羟丙基甲基纤维素K100M1-3重量份、壳聚糖1-3重量份、卡波姆934P 1-3重量份,微晶纤维素2-7重量份,混匀,加入20-40%氯化钠水溶液10-15体积份,采用挤出滚圆法制备微丸,即得复方丹参黏附微丸;A compound salvia miltiorrhiza adherent pellet, which weighs 6-10 parts by weight of Danshen extract, 1-3 parts by weight of Panax notoginseng extract, 1-4 parts by weight of borneol inclusion compound, and 1-3 parts by weight of hydroxypropyl methylcellulose K100M parts by weight, 1-3 parts by weight of chitosan, 1-3 parts by weight of carbomer 934P, 2-7 parts by weight of microcrystalline cellulose, mix well, add 10-15 parts by volume of 20-40% aqueous sodium chloride solution, The pellets were prepared by extrusion and spheronization, and the compound salvia miltiorrhiza adhering pellets were obtained;

本发明复方丹参黏附微丸优选如下方法制备:The compound Danshen adherent pellets of the present invention are preferably prepared by the following method:

称取丹参提取物8.09重量份,三七提取物1.57重量份,冰片包合物2.176重量份,羟丙基甲基纤维素K100M、壳聚糖、卡波姆934P各2.5重量份,微晶纤维素5.56重量份,混匀,加入20-40%氯化钠水溶液,采用挤出滚圆法制备复方丹参黏附微丸,干燥即得。Weigh 8.09 parts by weight of Salvia miltiorrhiza extract, 1.57 parts by weight of Panax notoginseng extract, 2.176 parts by weight of borneol inclusion compound, 2.5 parts by weight each of hydroxypropyl methylcellulose K100M , chitosan, and carbomer 934P, microcrystalline fiber 5.56 parts by weight of Su, mixed evenly, adding 20-40% sodium chloride aqueous solution, adopting extrusion spheronization method to prepare compound salvia miltiorrhiza adhering pellets, and drying to obtain.

所述丹参提取物、三七提取物由常规方法制成;Described salvia miltiorrhiza extract, Panax notoginseng extract are made by conventional method;

所述冰片包合物由如下方法制成:Described borneol clathrate is made by following method:

称取倍他环糊精4-8重量份,置于球磨罐中,加入10-30体积份蒸馏水;称取冰片0.5-2重量份,加无水乙醇溶解,将该溶液加入球磨罐中,研磨,取出,与3-5℃放置过夜,滤过,用无水乙醇洗涤滤饼上吸附的冰片,置40-60℃减压干燥,研细过80目筛,即得冰片倍他环糊精包合物。Weigh 4-8 parts by weight of beta-cyclodextrin, place it in a ball milling jar, add 10-30 parts by volume of distilled water; weigh 0.5-2 parts by weight of borneol, add absolute ethanol to dissolve, add the solution into a ball milling jar, Grind, take out, place overnight at 3-5°C, filter, wash the adsorbed borneol on the filter cake with absolute ethanol, dry at 40-60°C under reduced pressure, grind finely and pass through an 80-mesh sieve to obtain borneol beta cyclopaste Fine clathrate.

所述丹参提取物或三七提取物优选如下方法制备:The salvia miltiorrhiza extract or Panax notoginseng extract is preferably prepared as follows:

丹参饮片或三七饮片,加6-10重量倍60-90%乙醇回流提取1-3次,每次1-2h,滤过,合并提取液,浓缩至稠膏,40-70℃减压干燥,得到丹参提取物或三七提取物。Danshen decoction pieces or Panax notoginseng decoction pieces, add 6-10 times by weight 60-90% ethanol to reflux extract 1-3 times, each time 1-2h, filter, combine extracts, concentrate to thick paste, dry under reduced pressure at 40-70°C , to obtain Danshen extract or Panax notoginseng extract.

本发明所述重量份与体积份的关系是g/ml的关系。The relationship between parts by weight and parts by volume in the present invention is the relationship of g/ml.

附图说明:Description of drawings:

图1复方丹参制剂中R1血药浓度-时间曲线图Fig. 1 R1 plasma concentration-time curve in the compound salvia miltiorrhiza preparation

图2复方丹参制剂中Rg1血药浓度-时间曲线图Fig. 2 Rg1 plasma concentration-time curve in compound Danshen preparation

图3复方丹参制剂中Re血药浓度-时间曲线图 Re blood drug concentration-time curve in Fig. 3 compound salvia miltiorrhiza preparation

图4复方丹参制剂中Rb1血药浓度-时间曲线图R b1 plasma concentration-time curve in Fig. 4 compound salvia miltiorrhiza preparation

图5复方丹参制剂中Rd血药浓度-时间曲线图R d plasma concentration-time curve in Fig. 5 compound salvia miltiorrhiza preparation

本发明以羟丙基甲基纤维素K100M、壳聚糖以及卡波姆934P为黏附材料,采用挤出滚圆制丸法,将复方丹参方制备成复方丹参黏附微丸,从而增加复方丹参方中各药物在体内的滞留时间,延长药物的体内释放,提高药物的生物利用度。本发明冰片采用倍他环糊精包合,包合技术可以有效防止生产及储存过程中冰片的挥发,增强冰片在制剂中的稳定性。The present invention uses hydroxypropyl methylcellulose K100M , chitosan and carbomer 934P as adhesive materials, and adopts the method of extruding and spheronizing pellets to prepare compound Danshen prescription into compound Danshen adherent pellets, thereby increasing the content of compound Danshen prescription. The residence time of each drug in the body prolongs the release of the drug in the body and improves the bioavailability of the drug. The borneol of the present invention is clathrated with beta-cyclodextrin, and the clathrate technology can effectively prevent volatilization of the borneol during production and storage, and enhance the stability of the borneol in the preparation.

实验例1:实施例1复方丹参黏附微丸黏附性能测试Experimental Example 1: Adhesion Performance Test of Compound Danshen Adhesive Pellets in Example 1

1体外黏附试验1 In vitro adhesion test

1.1组织残留法1.1 Tissue residue method

取新鲜猪小肠,用pH6.8磷酸盐缓冲液冲掉小肠中的内容物,剪成10cm肠段,纵向剪开,铺于玻璃板上,长尾夹固定。取微丸100粒,均匀撒在肠黏膜表面,于37℃人工肠液中振荡,振荡频率100次/min,在一定时间后计数滞留于肠黏膜表面的微丸个数,实验结果见表1.Fresh porcine small intestines were taken, and the contents of the small intestines were washed away with pH6.8 phosphate buffer solution, cut into 10cm intestines, cut lengthwise, spread on a glass plate, and fixed with long tail clips. Take 100 pellets, sprinkle them evenly on the surface of the intestinal mucosa, oscillate in the artificial intestinal fluid at 37°C, the oscillation frequency is 100 times/min, and count the number of pellets remaining on the surface of the intestinal mucosa after a certain period of time. The experimental results are shown in Table 1.

表1组织残留法黏附试验结果(n=2)Table 1 Results of adhesion test by tissue residue method (n=2)

1.2最小剥离力法1.2 Minimum peel force method

取新鲜猪小肠,用pH6.8磷酸盐缓冲液冲掉小肠中的内容物,剪成10cm肠段,纵向剪开,用四条2cm宽的胶带黏于小肠之上,两端各两条,互不重叠,中间留出2cm宽的空隙,称取0.5g黏附微丸,均匀撒在小肠之上,取pH6.8磷酸盐缓冲液0.5mL,滴在微丸之上,使微丸充分溶胀,取另一鲜猪小肠,纵向剪开,使内表面贴于小肠之上,上面盖一个同样大小的玻璃板,用6N的压力按压20min,让后放于剥离试验机上,夹住一段,开始,记录小肠开始时移动的数值即最大数值,此数值为最小剥离力,实验结果见表2。Take fresh porcine small intestine, wash away the contents in the small intestine with pH6.8 phosphate buffer solution, cut into 10cm intestine section, cut it longitudinally, and stick it on the small intestine with four 2cm wide adhesive tapes, two at each end, each other Do not overlap, leave a 2cm wide gap in the middle, weigh 0.5g of adhesive pellets, sprinkle evenly on the small intestine, take 0.5mL of pH6.8 phosphate buffer, drop on the pellets, make the pellets fully swell, Take another fresh pig small intestine, cut it longitudinally so that the inner surface sticks to the small intestine, cover it with a glass plate of the same size, press it with a pressure of 6N for 20 minutes, put it on the peeling tester, clamp a section, and start, Record the value that the small intestine moves at the beginning, that is, the maximum value, which is the minimum peeling force. The experimental results are shown in Table 2.

表2最小剥离力试验结果(n=2)Table 2 Minimum peel force test results (n=2)

2体内黏附试验2 In vivo adhesion test

SD大鼠,禁食24h,自由饮水。每只大鼠给予不同处方的微丸100粒,以1mL生理盐水灌服。给药后大鼠禁食禁水。4h后处死大鼠,解剖,取出胃及小肠,水平铺伸于白色搪瓷盘上,量取小肠的长度,纵向剖开,将小肠平均分为上、中、下三段,量取微丸在小肠各段存留长度。对微丸在小肠每一段的黏附长度进行加权,上段(L1)加权较大,中端(L2)次之,下端(L3)加权最小,黏附指数N=0.5L1+0.3L2+0.2L3,实验结果见表3。SD rats were fasted for 24 hours and had free access to water. Each rat was given 100 pellets of different prescriptions and fed with 1 mL of normal saline. After administration, the rats were fasted from food and water. After 4 hours, the rats were sacrificed, dissected, the stomach and small intestine were taken out, and spread horizontally on a white enamel plate. The remaining length of each segment of the small intestine. The adhesion length of the pellets in each section of the small intestine is weighted, the upper section (L 1 ) is more weighted, the middle section (L 2 ) is next, and the lower section (L 3 ) is the least weighted. Adhesion index N=0.5L 1 +0.3L 2 +0.2L 3 , see Table 3 for the experimental results.

表3体内黏附试验结果(n=2)Table 3 In vivo adhesion test results (n=2)

体内外黏附试验结果显示,本发明的复方丹参黏附微丸具有良好黏附性能。The results of in vivo and in vitro adhesion tests show that the compound Danshen adherent pellets of the present invention have good adhesion properties.

实验例2:实施例2复方丹参黏附微丸与普通复方丹参微丸中指标成分R1、Rb1、Re、Rd1、Rg1血药浓度对比考察Experimental Example 2: Comparative study on blood concentration of index components R 1 , Rb 1 , Re, Rd 1 , Rg 1 in Compound Danshen Adhesive Pellets and Common Compound Danshen Pellets in Example 2

体重240~260g的雄性SD大鼠12只,适应性喂养1星期,随机分为两组:组一为复方丹参黏附微丸组;组二为普通复方丹参微丸组。按2.4g/kg给药,于规定时间点眼眶取血0.5mL,置于肝素管中,5000r/min冷冻离心15min,取上清液200μL,精密加入10μL(500ng/mL)柴胡皂苷A和600μL乙腈,涡旋3min,14000r/min离心10min,取上清液于40℃真空浓缩仪中挥干。加入100μL 20%乙腈溶液复溶,涡旋2min,置超声仪中100w功率超声10min,14000r/min离心10min,反复离心三遍,取上清液作为供试品溶液。Twelve male SD rats weighing 240-260 g were fed adaptively for 1 week, and were randomly divided into two groups: Group 1 was the compound Danshen Zhuanzhuan pellet group; group 2 was the ordinary compound Danshen pellet group. Administer at 2.4g/kg, take 0.5mL of blood from the orbit at the specified time point, put it in a heparin tube, and centrifuge at 5000r/min for 15min, take 200μL of the supernatant, and add 10μL (500ng/mL) of saikosaponin A and 600 μL of acetonitrile, vortexed for 3 minutes, centrifuged at 14000 r/min for 10 minutes, and the supernatant was evaporated to dryness in a vacuum concentrator at 40°C. Add 100μL of 20% acetonitrile solution to redissolve, vortex for 2min, place in an ultrasonic instrument for 10min at 100w power, centrifuge at 14000r/min for 10min, repeat centrifugation three times, and take the supernatant as the test solution.

复方丹参黏附微丸和复方丹参普通制剂中指标成分R1、Rg1、Re、Rb1、Rd的平均血药浓度-时间曲线见图1-图5,且相应的药动拟合参数见表4-表8The average blood drug concentration-time curves of index components R1, Rg1, Re, Rb1, Rd in Compound Danshen Adhesive Pellets and Compound Danshen Ordinary Preparation are shown in Figure 1-Figure 5, and the corresponding pharmacokinetic fitting parameters are shown in Table 4-Table 8

表4 R1药动拟合参数(n=6,mean±SD)Table 4 R 1 pharmacokinetic fitting parameters (n=6, mean±SD)

注:*表示复方丹参黏附微丸与复方丹参普通制剂相比有显著性差异,P<0.05。Note: * indicates that there is a significant difference between compound Danshen sticky pellets and compound Danshen common preparation, P<0.05.

表5 Rg1药动拟合参数(n=6,mean±SD)Table 5 Pharmacokinetic fitting parameters of Rg 1 (n=6, mean±SD)

注:*表示复方丹参黏附微丸与复方丹参普通制剂相比有显著性差异,P<0.05。Note: * indicates that there is a significant difference between compound Danshen sticky pellets and compound Danshen common preparation, P<0.05.

表6 Re药动拟合参数(n=6,mean±SD)Table 6 Re pharmacokinetic fitting parameters (n=6, mean±SD)

注:*表示复方丹参黏附微丸与复方丹参普通制剂相比有显著性差异,P<0.05。Note: * indicates that there is a significant difference between compound Danshen sticky pellets and compound Danshen common preparation, P<0.05.

表7 Rb1药动拟合参数(n=6,mean±SD)Table 7 Pharmacokinetic fitting parameters of Rb 1 (n=6, mean±SD)

注:*表示复方丹参黏附微丸与复方丹参普通制剂相比有显著性差异,P<0.05。Note: * indicates that there is a significant difference between compound Danshen sticky pellets and compound Danshen common preparation, P<0.05.

表8 Rd药动拟合参数(n=6,mean±SD)Table 8 Pharmacokinetic fitting parameters of Rd (n=6, mean±SD)

注:*表示复方丹参黏附微丸与复方丹参普通制剂相比有显著性差异,P<0.05。Note: * indicates that there is a significant difference between compound Danshen sticky pellets and compound Danshen common preparation, P<0.05.

由以上结果可知,复方丹参黏附微丸中五种皂苷成分生物利用度均大于普通制剂。对于五种成分整体来讲,CLz/F均为黏附制剂明显低于普通制剂,且黏附制剂的AUC和Cmax均显著高于普通制剂,说明黏附制剂在体内起到了黏附效果,黏附在黏膜表明药物与其接触更紧密,吸收的效率更高,同时延长了药物的有效吸收时间,给机体提供了更大的血药浓度,从而使生物利用度得到了显著提高,提供更好的疗效。From the above results, it can be seen that the bioavailability of the five saponin components in the compound Danshen Adhesive Pellets is greater than that of the common preparation. For the five ingredients as a whole, the CLz/F of the adhesive preparation was significantly lower than that of the common preparation, and the AUC and Cmax of the adhesive preparation were significantly higher than that of the common preparation, indicating that the adhesive preparation played an adhesive effect in vivo, and adhesion on the mucous membrane indicated The drug is in closer contact with it, and the absorption efficiency is higher. At the same time, the effective absorption time of the drug is prolonged, and a greater blood concentration is provided to the body, so that the bioavailability is significantly improved and better curative effect is provided.

实施例1:Example 1:

丹参饮片450g加8倍量70%乙醇回流提取2次,每次1.5h,滤过,合并提取液,浓缩至稠膏,60℃减压干燥,得到丹参提取物,出膏率为42.8%,丹参提取物研细,过80目筛,备用;三七饮片141g加8倍量70%乙醇回流提取2次,每次1.5h,滤过,合并提取液,浓缩至稠膏,60℃减压干燥,得到三七提取物,出膏率为26.43%,三七提取物研细,过80目筛,备用;称取倍他环糊精6g,置于球磨罐中,加入20mL蒸馏水;称取冰片1g(过80目筛),加2mL无水乙醇溶解,将该溶液加入球磨罐中,转速300r·min-1,研磨30min,取出,于4℃冰箱中放置过夜,滤过,用5mL无水乙醇洗涤滤饼上吸附的冰片,置50℃减压干燥6h,即得冰片倍他环糊精包合物,研细过80目筛,备用,出膏率为680%。Add 450g of Danshen decoction pieces and add 8 times the amount of 70% ethanol to reflux and extract twice, each time for 1.5h, filter, combine the extracts, concentrate to a thick paste, and dry under reduced pressure at 60°C to obtain the Danshen extract with a paste yield of 42.8%. Grind the salvia miltiorrhiza extract, pass through a 80-mesh sieve, and set aside; Add 8 times the amount of 70% ethanol to 141g of Panax notoginseng decoction pieces, reflux and extract twice, each time for 1.5h, filter, combine the extracts, concentrate to a thick paste, and depressurize at 60°C Dry to obtain the extract of Panax notoginseng, the yield of the paste is 26.43%. The extract of Panax notoginseng is ground, passed through an 80-mesh sieve, and set aside; weigh 6g of beta-cyclodextrin, put it in a ball mill jar, add 20mL of distilled water; weigh Add 1g of borneol (passed through 80 mesh sieve), add 2mL of absolute ethanol to dissolve, put the solution into a ball mill jar at a speed of 300r·min -1 , grind for 30min, take it out, put it in a refrigerator at 4°C overnight, filter, and use 5mL of Wash the adsorbed borneol on the filter cake with water and ethanol, and dry under reduced pressure at 50°C for 6 hours to obtain the borneol-beta-cyclodextrin inclusion compound, which is ground and passed through an 80-mesh sieve for later use. The yield of the paste is 680%.

称取丹参提取物8.09g(丹参出膏率为42.5%),三七提取物1.57g(三七出膏率26.43%),冰片包合物2.176g(出膏率为680%),羟丙基甲基纤维素K100M、壳聚糖、卡波姆934P各2.5g,微晶纤维素5.56g,混匀,加入30%氯化钠水溶液12mL,采用挤出滚圆法制备复方丹参黏附微丸,挤出速度为25r/min,滚圆速度为1600r/min,滚圆时间为4min,干燥时间为2h。Take by weighing 8.09g of Salvia miltiorrhiza extract (the yield of salvia miltiorrhiza is 42.5%), 1.57g of Radix Notoginseng extract (26.43% of the yield of Panax notoginseng), 2.176g of borneol inclusion compound (the yield of cream of Radix Notoginseng is 680%), hydroxypropyl 2.5 g each of methylcellulose K100M , chitosan, and carbomer 934P, 5.56 g of microcrystalline cellulose, mixed evenly, added 12 mL of 30% sodium chloride aqueous solution, and prepared compound Danshen adherent pellets by extrusion spheronization. The extrusion speed is 25r/min, the spheronization speed is 1600r/min, the spheronization time is 4min, and the drying time is 2h.

实施例2:丹参饮片450g加8倍量70%乙醇回流提取2次,每次1.5h,滤过,合并提取液,浓缩,60℃减压干燥,得到丹参提取物,出膏率为44.92%,丹参提取物研细,过80目筛,备用;三七饮片141g加8倍量70%乙醇回流提取2次,每次1.5h,滤过,合并提取液,浓缩,60℃减压干燥,得到三七提取物,出膏率为29.88%,三七提取物研细,过80目筛,备用;称取倍他环糊精6g,置于球磨罐中,加入20mL蒸馏水;称取冰片1g(过80目筛),加2mL无水乙醇溶解,将该溶液加入球磨罐中,300r·min-1,研磨30min,取出,与4℃冰箱中放置过夜,滤过,用5mL无水乙醇洗涤滤饼上吸附的冰片,置50℃减压干燥6h,研细过80目筛,即得冰片倍他环糊精包合物,备用,出膏率为680%。Example 2: 450 g of Danshen decoction pieces were added with 8 times the amount of 70% ethanol for reflux extraction twice, each time for 1.5 hours, filtered, combined extracts, concentrated, and dried under reduced pressure at 60°C to obtain Danshen extract with a paste yield of 44.92% , the extract of Salvia miltiorrhiza was finely ground, passed through a 80-mesh sieve, and set aside; 141g of Sanqi decoction pieces were added with 8 times the amount of 70% ethanol for reflux extraction twice, each time for 1.5h, filtered, combined extracts, concentrated, and dried under reduced pressure at 60°C. The extract of Panax notoginseng was obtained, and the paste yield was 29.88%. The extract of Panax notoginseng was finely ground, passed through an 80-mesh sieve, and set aside; weighed 6g of beta-cyclodextrin, put it in a ball mill jar, added 20mL of distilled water; weighed 1g of borneol (through a 80-mesh sieve), add 2 mL of absolute ethanol to dissolve, put the solution into a ball mill jar, grind for 30 min at 300 r·min -1 , take it out, place it in a refrigerator at 4°C overnight, filter, and wash with 5 mL of absolute ethanol The borneol adsorbed on the filter cake was dried under reduced pressure at 50°C for 6 hours, ground and passed through an 80-mesh sieve to obtain the borneol-beta-cyclodextrin inclusion compound, which was ready for use, and the paste yield was 680%.

丹参提取物8.02g(出膏率44.92%),三七提取物1.67g(出膏率29.88%),冰片包合物2.176g,羟丙基甲基纤维素K100M、壳聚糖、卡波姆934P,各2.5g,微晶纤维素5.634g,混匀,加入30%氯化钠水溶液12mL,挤出速度为25r/min,滚圆速度为1600r/min,滚圆时间为4min,干燥时间为2h,即得。Salvia miltiorrhiza extract 8.02g (cream yield 44.92%), Panax notoginseng extract 1.67g (cream yield 29.88%), borneol inclusion compound 2.176g, hydroxypropyl methylcellulose K100M , chitosan, carbomer 934P, 2.5g each, 5.634g microcrystalline cellulose, mix well, add 12mL of 30% sodium chloride aqueous solution, extrusion speed is 25r/min, spheronization speed is 1600r/min, spheronization time is 4min, drying time is 2h, Instantly.

Claims (8)

1. a kind of compound Danshen Root sticks micropill, it is characterised in that the micropill is made by the following method:
Weigh Salvia root P.E 6-10 parts by weight, Notogineng Extract 1-3 parts by weight, borneol inclusion compound 1-4 parts by weight, hydroxypropyl first Base celluloseK100M1-3 parts by weight, chitosan 1-3 parts by weight, carbomer940 1-3 parts by weight, microcrystalline cellulose 2-7 weight Part, mix, add 20-40% sodium-chloride water solution 10-15 parts by volume, micropill is prepared using extrusion spheronization method, produce compound pellet Ginseng sticks micropill;
The Salvia root P.E, Notogineng Extract have conventional method to be made;
The borneol inclusion compound is made by the following method:
Betadex 4-8 parts by weight are weighed, are placed in ball grinder, add 10-30 parts by volume distilled water;Weigh borneol 0.5-2 Parts by weight, add absolute ethyl alcohol to dissolve, the solution is added in ball grinder, grind, take out, stood overnight with 3-5 DEG C, filter, use The borneol that adsorbs on absolute ethyl alcohol washing filter cake, puts 40-60 DEG C and is dried under reduced pressure, the finely ground mesh sieve of mistake 80, produces borneol times his ring paste Inclusion compounds.
2. compound Danshen Root as claimed in claim 1 sticks micropill, it is characterised in that the micropill is made by the following method:
Weigh the parts by weight of Salvia root P.E 8.09, the parts by weight of Notogineng Extract 1.57, the parts by weight of borneol inclusion compound 2.176, hydroxypropyl Ylmethyl celluloseK100M, chitosan, each 2.5 parts by weight of carbomer940, the parts by weight of microcrystalline cellulose 5.56, mix, add The parts by volume of 30% sodium-chloride water solution 12, compound Danshen Root is prepared using extrusion spheronization method and sticks micropill.
3. compound Danshen Root as claimed in claim 1 or 2 sticks micropill, it is characterised in that the Salvia root P.E or pseudo-ginseng extraction Thing is prepared by the following method:
Salvia piece or notoginseng decoction piece, add 6-10 times of weight 60-90% alcohol refluxs to extract 1-3 times, each 1-2h, filter, close And extract solution, thick paste is concentrated into, 40-70 DEG C is dried under reduced pressure, and obtains Salvia root P.E or Notogineng Extract.
4. compound Danshen Root as claimed in claim 1 or 2 sticks micropill, it is characterised in that the borneol inclusion compound is by the following method Prepare:
The parts by weight of betadex 6 are weighed, are placed in ball grinder, add 20 parts by volume distilled water;The parts by weight of borneol 1 are weighed, add 2 Parts by volume absolute ethyl alcohol dissolves, and the solution is added in ball grinder, 300rmin-1, 30min is ground, is taken out, and in 4 DEG C of refrigerators Stand overnight, filter, the borneol adsorbed on filter cake is washed with 5 parts by volume absolute ethyl alcohols, 50 DEG C is put and is dried under reduced pressure 6h, finely ground mistake 80 Mesh sieve, produce borneol betadex inclusion compound.
5. a kind of compound Danshen Root sticks the preparation method of micropill, it is characterised in that this method is:
Weigh Salvia root P.E 6-10 parts by weight, Notogineng Extract 1-3 parts by weight, borneol inclusion compound 1-4 parts by weight, hydroxypropyl first Base celluloseK100M1-3 parts by weight, chitosan 1-3 parts by weight, carbomer940 1-3 parts by weight, microcrystalline cellulose 2-7 weight Part, mix, add 20-40% sodium-chloride water solution 10-15 parts by volume, micropill is prepared using extrusion spheronization method, produce compound pellet Ginseng sticks micropill;
The Salvia root P.E, Notogineng Extract have conventional method to be made;
The borneol inclusion compound is made by the following method:
Betadex 4-8 parts by weight are weighed, are placed in ball grinder, add 10-30 parts by volume distilled water;Weigh borneol 0.5-2 Parts by weight, add absolute ethyl alcohol to dissolve, the solution is added in ball grinder, grind, take out, stood overnight with 3-5 DEG C, filter, use The borneol that adsorbs on absolute ethyl alcohol washing filter cake, puts 40-60 DEG C and is dried under reduced pressure, the finely ground mesh sieve of mistake 80, produces borneol times his ring paste Inclusion compounds.
6. compound Danshen Root as claimed in claim 1 sticks the preparation method of micropill, it is characterised in that this method is:
Weigh the parts by weight of Salvia root P.E 8.09, the parts by weight of Notogineng Extract 1.57, the parts by weight of borneol inclusion compound 2.176, hydroxypropyl Ylmethyl celluloseK100M, chitosan, each 2.5 parts by weight of carbomer940, the parts by weight of microcrystalline cellulose 5.56, mix, add The parts by volume of 30% sodium-chloride water solution 12, compound Danshen Root is prepared using extrusion spheronization method and sticks micropill.
7. compound Danshen Root as claimed in claim 1 or 2 sticks the preparation method of micropill, it is characterised in that red described in this method Conopsea extraction or Notogineng Extract are prepared by the following method:
Salvia piece or notoginseng decoction piece, add 6-10 times of weight 60-90% alcohol refluxs to extract 1-3 times, each 1-2h, filter, close And extract solution, thick paste is concentrated into, 40-70 DEG C is dried under reduced pressure, and obtains Salvia root P.E or Notogineng Extract.
8. compound Danshen Root as claimed in claim 1 or 2 sticks the preparation method of micropill, it is characterised in that ice described in this method Piece inclusion compound is prepared by the following method:
The parts by weight of betadex 6 are weighed, are placed in ball grinder, 20 parts by volume distilled water is added, weighs the parts by weight of borneol 1, add 2 Parts by volume absolute ethyl alcohol dissolves, and the solution is added in ball grinder, 300rmin-1, 30min is ground, is taken out, and in 4 DEG C of refrigerators Stand overnight, filter, the borneol adsorbed on filter cake is washed with 5 parts by volume absolute ethyl alcohols, 50 DEG C is put and is dried under reduced pressure 6h, finely ground mistake 80 Mesh sieve, produce borneol betadex inclusion compound.
CN201710609695.7A 2017-07-25 2017-07-25 A kind of compound Danshen Root sticks micropill and its preparation technology Pending CN107468752A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710609695.7A CN107468752A (en) 2017-07-25 2017-07-25 A kind of compound Danshen Root sticks micropill and its preparation technology

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710609695.7A CN107468752A (en) 2017-07-25 2017-07-25 A kind of compound Danshen Root sticks micropill and its preparation technology

Publications (1)

Publication Number Publication Date
CN107468752A true CN107468752A (en) 2017-12-15

Family

ID=60596640

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710609695.7A Pending CN107468752A (en) 2017-07-25 2017-07-25 A kind of compound Danshen Root sticks micropill and its preparation technology

Country Status (1)

Country Link
CN (1) CN107468752A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116509924A (en) * 2023-04-11 2023-08-01 浙江中医药大学附属第三医院(浙江省中山医院) A kind of Yuanhubai and Sanwei adhesion pellets and its preparation method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1349818A (en) * 2001-10-24 2002-05-22 沈阳药科大学 Effective part group in red sage mixture and its delayed release prepn. medicinal use and prepn process
CN1596917A (en) * 2003-09-16 2005-03-23 成都尚科药业有限公司 Preparation method of compound red-rooted salvia micro pill
CN101229225A (en) * 2007-11-23 2008-07-30 复旦大学 Salvia phenolic acid gastric retention preparation
WO2015115512A1 (en) * 2014-01-29 2015-08-06 独立行政法人産業技術総合研究所 Method for preparing water extract of ashwagandha leaves which has enhanced anti-cancer activity utilizing cyclodextrin, and pharmaceutical composition containing ashwagandha leaves

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1349818A (en) * 2001-10-24 2002-05-22 沈阳药科大学 Effective part group in red sage mixture and its delayed release prepn. medicinal use and prepn process
CN1596917A (en) * 2003-09-16 2005-03-23 成都尚科药业有限公司 Preparation method of compound red-rooted salvia micro pill
CN101229225A (en) * 2007-11-23 2008-07-30 复旦大学 Salvia phenolic acid gastric retention preparation
WO2015115512A1 (en) * 2014-01-29 2015-08-06 独立行政法人産業技術総合研究所 Method for preparing water extract of ashwagandha leaves which has enhanced anti-cancer activity utilizing cyclodextrin, and pharmaceutical composition containing ashwagandha leaves

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
傅超美等主编: "《药用辅料学》", 31 October 2008, 中国中医药出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116509924A (en) * 2023-04-11 2023-08-01 浙江中医药大学附属第三医院(浙江省中山医院) A kind of Yuanhubai and Sanwei adhesion pellets and its preparation method

Similar Documents

Publication Publication Date Title
WO2018133563A1 (en) Panax plant extract and pharmaceutical composition and use thereof
CN105287614B (en) A kind of Dengyin naotong pharmaceutical composition and preparation method thereof, preparation and application
CN108186877A (en) For the Chinese medicine composition of syndrome of blood stasis due to qi deficiency myocardial infarction secondary prevention
CN102488815B (en) Buccal tablet for reducing blood sugar
CN101229225A (en) Salvia phenolic acid gastric retention preparation
CN107468752A (en) A kind of compound Danshen Root sticks micropill and its preparation technology
CN102266452A (en) Chinese medicinal composition for enhancing anoxia endurance and preparation method and application thereof
CN103622942A (en) Levodopa/carbidopa compound sustained-release suspension and preparation method thereof
CN104013674B (en) It is a kind of to treat Chinese medicine composition of chronic heart failure and its preparation method and application
JP2013514283A (en) Traditional Chinese medicine containing Danshen extract and Sanki extract, and their use
CN105476870B (en) A kind of medicated toothpaste containing Gastrodin
CN104740054B (en) A kind of pharmaceutical composition for preventing and treating myocardial ischemia and its preparation method and application
CN102935177A (en) A traditional Chinese medicine composition for treating Sjögren&#39;s syndrome, its preparation method and application
CN104490965B (en) Application of Panax ginseng polysaccharide, Panax ginseng total saponins and Panax ginseng saponin V
CN103142695B (en) Pharmaceutical composition for prevention and treatment of chronic glomerular diseases and preparation method of pharmaceutical composition
CN103211961A (en) Traditional Chinese medicine composition for treating chronic renal insufficiency
CN106539892A (en) A kind of Radix Ranunculi Ternati Chinese medicine composition and its preparation method and application
CN115154508B (en) Preparation method and application of traditional Chinese medicine compound nanoparticles
CN102078593A (en) Application of toad peptide antibiotic for preparing medicines for curing diabetic foot
CN112386654B (en) Traditional Chinese medicine composition, extract, preparation method and application thereof
CN116211944B (en) Traditional Chinese medicine composition, preparation and application thereof
CN113069466B (en) Application of purslane polysaccharide in preparation of acute lung injury resistant medicine
CN103385881A (en) Pharmaceutical composition of salviae miltiorrhizae extract for treating cardiovascular and cerebrovascular diseases and use thereof
CN103405442A (en) Pharmaceutical composition of salvia miltiorrhiza extractive, and use thereof
CN119770568A (en) A Chinese medicine composition, pharmaceutical preparation and use

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20171215